OUR NEWS IS BELOW:
Attention All Commercial Users of QTdrugs Technology
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
For Licensing information, please click here.
Prolongation of the QT interval is a well-established risk factor that predicts increased mortality from sudden cardiac death.1 Identification of patients with the highest risk of QT prolongation and associated adverse outcomes has been facilitated…
Nature Reviews of Cardiology invited Dr. Raymond L. Woosley to author an article, assessing cardiovascular drug safety for clinical decision-making which appears in Volume 10 of the Cardiology Review.
The Annual Review of Pharmacology and Toxicology invited Dr. Raymond Woosley to author an article on the past, present and future of drug regulation which appears in Volume 53 of the Review.
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.